Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Latest Urinary urgency Stories

2014-02-06 08:27:59

~Positive Coverage Decision Adds 2.2 Million Covered Lives for Up to Two Years of Treatment with Urgent PC MINNEAPOLIS, Feb. 6, 2014 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI) a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that Independence Blue Cross (IBC) has written a positive coverage policy for Percutaneous Tibial Nerve Stimulation (PTNS) delivered via Uroplasty's...

2013-12-23 08:26:09

~Positive Coverage Decision Adds 2.7 Million Covered Lives for Urgent PC MINNEAPOLIS, Dec. 23, 2013 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that Medical Mutual has written a positive coverage policy for Percutaneous Tibial Nerve Stimulation (PTNS) delivered via Uroplasty's Urgent(®) PC Neuromodulation System for treatment...

2013-12-10 08:29:41

Seasoned Executive Adds Expertise in Developing, Branding and Commercializing Medical Device Products to UPI Team MINNEAPOLIS, Dec. 10, 2013 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI) a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that David B. Perry has joined the Company as Vice President of Marketing. He joins Uroplasty with nearly 20 years of experience developing,...

2013-12-09 23:27:51

The Interstitial Cystitis Association (ICA) invites investigators from all disciplines interested in studying interstitial cystitis (IC), also known as painful bladder syndrome or bladder pain syndrome, to submit an application for the $25,000 2014 ICA Pilot Research Grant. McLean, VA (PRWEB) December 09, 2013 The Interstitial Cystitis Association (ICA) invites investigators from all disciplines interested in studying interstitial cystitis (IC), also known as painful bladder syndrome or...

2013-12-04 08:29:02

Company Expects to End 2013 with Procedure Coverage for More Than 140 Million Lives, Up from 124 Million Lives as of 12/31/2012 MINNEAPOLIS, Dec. 4, 2013 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI) a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today provided an update on reimbursement coverage for Percutaneous Tibial Nerve Stimulation (PTNS) procedures delivered via the Company's...

2013-10-29 08:31:49

MINNEAPOLIS, Oct. 29, 2013 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that Humana, Inc. has written a positive coverage policy for Percutaneous Tibial Nerve Stimulation (PTNS) delivered via Uroplasty's Urgent(®) PC Neuromodulation System for treatment of overactive bladder (OAB) and associated symptoms of urinary urgency,...

2013-07-24 23:04:25

The Interstitial Cystitis Association hosted the 2013 Patient Forum in Philadelphia on Saturday, June 29th. ICA empowered patients and caregivers with the need-to-know tools for successful management and treatment of interstitial cystitis. McLean, VA (PRWEB) July 24, 2013 The Interstitial Cystitis Association (ICA) hosted the 2013 Patient Forum in Philadelphia on Saturday, June 29th. ICA empowered patients and caregivers with the need-to-know tools for successful management and treatment...

2013-05-30 16:26:47

MINNEAPOLIS, May 30, 2013 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that effective June 1, 2013, Wisconsin Physicians Services (WPS) will begin coverage for Posterior Tibial Nerve Stimulation (PTNS) for treatment of overactive bladder (OAB) and associated symptoms of urinary urgency, urinary frequency and urge incontinence. WPS, a...

2013-05-10 08:24:21

OAB patients treated with Urgent® PC over 36 months sustained their urinary symptom improvement MINNEAPOLIS, May 10, 2013 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ:UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today highlighted the 3-year results of the STEP Study on percutaneous tibial nerve stimulation (PTNS) treatments for overactive bladder (OAB) using Uroplasty's Urgent(®)...

2013-03-21 23:04:44

ICA released over 1,000 billboards at the beginning of March to help those suffering from IC symptoms, reoccurring frequency, pain, and urgency, take the steps to receiving optimal care. The goal of the campaign is to direct viewers to the http://www.ichelp.org website where they can get reliable information about IC. McLean, VA (PRWEB) March 21, 2013 The Interstitial Cystitis Association (ICA) launched a major public awareness campaign this month. ICA released over 1,000 billboards at the...